Trailing Twelve Months Revenue Growth: chromadex.com (CDXC)

Brandmark of chromadex.com (CDXC)

The TTM revenue change demonstrates the environmental vector of ChromaDex Corporation (CDXC) through the implementation of ESG standards and packaging recycling. A global patent shield for the synthesis of Tru Niagen serves as a profit safeguard, restricting competitor access. The current 21.20 metric determines the parameter's status amid fierce competition for brand recognition in the unregulated longevity dietary supplement market.

CDXC ChromaDex Corp. Sales Growth YoY (TTM) (02/11/2024 - 02/20/2024)

ChromaDex (CDXC) - metric breakdowns and financial figures

- company stock exchange capitalization indicators:
Fundamental company valuation:ChromaDex Corp. - CDXC
Flagship merchandise of chromadex.com

Effective international distribution of patented components under the stable management of ChromaDex Corporation (CDXC) correlates directly with the revenue dynamics shown on this 12-month YoY sales change chart. This indicator measures the daily growth rate of TTM annual turnover, adjusted for one-time write-offs, allowing investors to assess the real scalability of the business and confirm the sustainability of the asset's market value.